HAEMONETICS CORP/MASS (HAE) Stock News
NYSE:HAE - New York Stock Exchange, Inc. - US4050241003 - Common Stock
HAE Latest News and Analysis
Interesting HAE Put And Call Options For September 19th
Noteworthy Tuesday Option Activity: WGS, HAE, ABT
Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better...
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2025 financial results at 6:00 am...
Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare...
Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better...
Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2025, which ended September 28, 2024,...
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2025 financial results at 6:00 am...
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient...
Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2025, which ended June 29, 2024, are...
Sotera Health Appoints Christopher Simon to the Board of Directors
Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better...
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2025 financial results at 6:00 am...
Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient...